COVID-19
Long COVID-19 associated with elevated interferon levels
In this latest video from MedCram, Dr. Seheult discusses a research paper that discusses long COVID and interferon levels. He explains that the immune system is made up of the innate immune system and the adaptive immune system. The adaptive immune system is the part of the immune system that makes antibodies and takes a…
Read MoreDisease X: how to prepare for the next pandemic
In this latest video from Dr. Seheult of Medcram, he discusses the World Economic Forum meeting that occurred in Switzerland where world leaders met to discuss the threat of a hypothetical “Disease X” pandemic. The discussion was stemming from a possible future pandemic that could be up to 20 times more deadly than what we…
Read MoreCovid 19 risks of infection and early treatment recommendations
COVID-19 risk factors In this video from Medcram, Dr. Seheult discusses a study on a survey that had been done in older adults. The study took place in Greece. It collected data from 8121 community dwelling older adults over the age of 65. After factoring for exclusions, there were about 5100 adults remaining. This was…
Read MoreCase Study: Sunlight Treatment for Hospitalized COVID Patient – Outcome and Implications
In this latest video from MedCram, Dr. Seheult, discusses a case study of a patient who was hospitalized with COVID-19 and how sunlight treatment impacted his outcome. Dr. Seheult discusses how when the pandemic first started, he was searching for answers on how to save his patients. MedCram created multiple videos dating back to 2020…
Read MoreInterferon’s Role in SARS-CoV2 Infection and the Role of Hydrotherapy
In this latest video from MedCram, Dr. Seheult discusses interferon and hydrotherapy. He reminds us that MedCram had first discussed hydrotherapy back in March of 2020 with videos update 46 and update 47. There is new research that is adding more validity to the use of interferon and what we can do in our bodies…
Read MoreVAERS mRNA Death Curve Explained Clearly
In this video from MedCram, Dr. Seheult delves into a deep dive of the VAERS reporting system. He states it is important that we review the VAERS report for the COVID-19 vaccines especially as we continue to use boosters and the “cold” season is coming upon us and more people will be making decisions as…
Read MoreCurrent COVID Risk Assessment: BA.2.86 Variant, Boosters, and More
In this current video from MedCram, Dr. Seheult explores the latest COVID risk assessment on the new BA.2.86 variant also known as Pirola. Is there an uptick in COVID-19? Testing nowadays is inconsistent, so Dr. Seheult went to review the analysis from wastewater data. The graphs do show that there is some increase in the…
Read MorePhotobiomodulation for Long COVID
In this video, Dr. Seheult of MedCram explores the use of photobiomodulation in the treatment of long COVID. Dr. Seheult believes that sunlight may be a beneficial modality for treating it. He notes that the NIH has poured $1 billion dollars into long COVID research and doesn’t have much to show for it. He shows…
Read MoreCOVID-19 EG.5 variant: hospitalizations on the rise
In this video, Dr. Seheult of MedCram discusses the EG.5 COVID-19 sub-variant, and the rise of COVID-19 related hospitalizations. It has been noted that hospitalizations for COVID-19 are increasing steadily. As an ICU doctor, Dr. Seheult reports that none of these patients have gone into the intensive care unit in his personal situation. He states…
Read MoreU.S. excess mortality down
In this video, Dr. Seheult of MedCram, discusses the current excess mortality statistics and explains how they are calculated. In a graph, Dr. Seheult shows the deaths per week for multiple chronic diseases some of which include heart disease, stroke, diabetes, etc. It is noted that for every single year, there is always a peak…
Read MoreVilobelimab for Severe Covid-19 and possibly other diseases
In this latest MedCram video, Dr. Seheult discusses a promising new drug that is being added to the arsenal of treatments against COVID-19. It is a new monoclonal antibody called vilobelimab. What does vilobelimab do? This drug has been given emergency use authorization not only for COVID-19 but it may also be applied to other…
Read MoreNew COVID 19 Variant: Arcturus (Omicron XBB.1.16) Increasing. What’s the Significance?
In this video, Dr. Seheult of MedCram discusses the latest new Omicron subvariant named Arcturus. This variant has been found in 22 countries around the world but recently has been discussed in the news due to rising cases in India. It is known as Omicron XBB.1.16. Is this variant more dangerous? From the data thus…
Read More